Revisiting the Concept of DIC: A Phenotype-guided Framework for Modern Hemostatic Medicine. [PDF]
Crochemore T, Scarlatescu E.
europepmc +1 more source
Irradiation Enhances the Biomedical Functional Characteristics of Collagen Sponges: A Potential Strategy for Medical Collagen Sponge Modification. [PDF]
Qin J, Wu H, Lan B, Yao L, Wu Z.
europepmc +1 more source
Thromboelastography variables, immune markers, and endothelial factors associated with shock and NPMODS in children with severe sepsis [PDF]
Ignell, Steven P +3 more
core +1 more source
Role of leukocytes in hemostasis during orthotopic liver transplantation [PDF]
Bechstein, W. O. +8 more
core +1 more source
Clinical Evaluation of the Hemostatic Efficacy and Safety of a Biodegradable Hemostatic Agent, Hemogram: A Comparative Study with Arista™ AH. [PDF]
Min SK +5 more
europepmc +1 more source
Tissue-type-plasminogen-activator-associated fibrinolysis in orthotopic liver transplantation [PDF]
Bontempo, FA +5 more
core
A Comprehensive Review of SURGICEL®: Efficacy, Applications, and Radiological Insights in Surgery. [PDF]
Halalmeh DR +5 more
europepmc +1 more source
Hemostatic rescue with rFVIIa in Bernard-Soulier syndrome refractory to HLA-matched platelet transfusion. [PDF]
Okamoto Y +6 more
europepmc +1 more source
Genetic Contribution to Asthma Informs Acute Chest Syndrome Pathophysiology and Risk Stratification
ABSTRACT Acute chest syndrome (ACS) is a severe complication of sickle cell disease (SCD) occurring in ~50% of patients, some presenting frequent episodes. We lack tools to identify patients at high risk of ACS occurrence or frequent episodes. Epidemiological studies have found an association between asthma and ACS, but whether this link is causal is ...
Sara El Aouhel +10 more
wiley +1 more source
Selinexor and Venetoclax Combination in Patients With Relapsed or Refractory Acute Myeloid Leukemia
ABSTRACT Preclinical studies showed a synergistic antileukemia activity with combination of selective XPO1 inhibitor selinexor (SEL) and venetoclax (VEN), with potential to overcome VEN resistance by reducing the anti‐apoptotic protein MCL1. In an investigator‐sponsored, open‐label, phase Ib study (NCT03955783), adult patients with relapsed or ...
Somedeb Ball +11 more
wiley +1 more source

